Professor Calum MacRae

Professor Calum MacRae

Harvard Medical School, Boston (United States of America)

Member of:

Dr. MacRae works on the human genetics of disease, developmental contributions to health and disease, and on novel approaches to drug discovery. He has a longstanding interest in the incorporation of genomics and other large-scale datasets into clinical practice, systematic approaches to the discovery of new translatable phenotypes, and in the integration of care and discovery.

Presentations

Where will artificial intelligence be used in cardiology.

Event: ESC Congress 2019

Topic: Hospital Information Systems, Electronic Medical Records, Clinical Decision Support

Session: The digital revolution in cardiology

Access

Treating laminopathy

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Frontiers in the treatment of cardiomyopathies

Access

Towards a cure: can pharmacology help?

Event: ESC Congress 2016

Topic: Ion channels and electrophysiology

Session: Novel targets in arrhythmias

Access

Phase 2 study of A797, an oral, selective p38 mitogen-activated protein kinase inhibitor, in patients with lamin A/C-related dilated cardiomyopathy

Event: ESC Congress 2016

Topic: Pharmacologic therapy

Session: Cardiomyopathies

Access

Zebrafish as a tool to identify novel therapies for human cardiovascular disease

Event: ESC Congress 2016

Topic: Integrative physiology and control mechanisms

Session: The value of innovative animal models for cardiovascular disease - From flies to pigs

Access

Professor Calum MacRae

Biography

Contributor content

Where will artificial intelligence be used in cardiology.

Treating laminopathy

Towards a cure: can pharmacology help?

Phase 2 study of A797, an oral, selective p38 mitogen-activated protein kinase inhibitor, in patients with lamin A/C-related dilated cardiomyopathy

Zebrafish as a tool to identify novel therapies for human cardiovascular disease

ESC 365 is supported by